Abstract Epidemiological data show that colorectal cancer (CRC) is the second most frequent malignancy worldwide.
Introduction
Despite great progress in our knowledge regarding the development and treatment of cancer, sporadic colorectal cancer (sCRC) still remains one of the most common cancers and the cause of a high proportion of cancer-related deaths in developed countries [1, 2] . There is a growing body of evidence that an individual's susceptibility to sCRC depends on both his/her an individual's genetic profile (so called ''genetic makeup'') and exposure to exogenous and endogenous carcinogens (DNA damaging agents) [3, 4] .
The risk of sporadic CRC is modified mainly (approximately 80%) by environmental and lifestyle factors that could be a source of DNA-damaging carcinogens [5] . Thus, the capacity for DNA-repair, determined by the polymorphisms in DNA-repair genes, seems to be essential in ensuring genomic (molecular and chromosomal) stability, which in turn is strongly associated with the risk of sCRC. DNA-repair genes act on a variety of pathways depending on the type of DNA-damage. The base excision repair (BER) pathway is involved mainly in the removal of oxidative DNA damage induced by reactive oxygen species [5, 6] . The 8-oxoguanine DNA glycosyslase (OGG1) gene encodes a DNA repair protein that removes 8-oxo-7,8-dihydroguanine (8-oxoG) [5] . The variant allele of the Ser326Cys polymorphism is associated with higher level of genetic instability and seems to be associated with an increased risk of lung, esophagus, prostate cancer as well as ALL (acute lymphoblastic leukemia) among children [7] [8] [9] . Opinion is divided as to whether there is an association between OGG1, Ser326Cys and colorectal cancer [8, 10, 11] . The XRCC1 gene encodes a protein that interacts with other DNA-repair proteins, such as Lig3, Polb and PARP, creating a complex involved in shortpatch BER [6] . Two polymorphisms: Arg194Trp and Arg399Gln have been widely studied in cancer epidemiology. It has been proven that Arg194Arg individuals have a higher level of DNA damage compared to those with one or two Trp variant alleles, while the highest level of DNA damage is observed in Gln399Gln homozygotes [12] . The 194Trp variant has also been found to be protective against lung cancer, although it is associated with an increased risk of CRC [8] . The results for the Arg399Gln polymorphism of the XRCC1 gene in colorectal cancer epidemiology are very ambiguous [13] [14] [15] [16] [17] [18] .
Nucleotide excision repair (NER) is involved in the removal of DNA thymine dimmers and bulky adducts, induced by UV light, tobacco smoke and environmental xenobiotics [19] . The NER pathway consists of about 30 genes called Xeroderma Pigmentosum (XP) or the excision repair cross-complementing group (ERCC). The XPA (-4) G/A variant localized in Kozak sequence near the ATGstart codon may influence the level of the XPA protein [20] . The presence of at least one G-allele is associated with a decreased risk of lung cancer in Caucasians, Koreans and Americans [21] . Nevertheless, Hansen et al. did not observe any statistically significant interaction between this polymorphism and the risk of CRC [22] .
The XPC protein is involved in the XPC-HR23B DNAdamage-recognition complex of GG-NER [19] . Three polymorphisms in XPC [A33512C in exon 15 (Lys939Gln)], the insertion/deletion poly AT (PAT) in intron 9 and the C/A polymorphism in intron 11 are in high linkage disequilibrium [23] . The XPC PAT?/? variant was shown to be associated with reduced capacity for DNA repair and an increased risk of lung cancer [23, 24] . The variant allele of the XPC exon 15 polymorphism has been found to be associated with the risk of bladder cancer [25] . The XPD gene encodes the helicase participating in the transcription factor IIH. The 312Asn and 751Gln variant alleles of XPD correlate with a reduced capacity for repairing bulky adducts [12] . However, the results of studies on XPD polymorphisms with regard to a variety of human cancers remain contradictory [22, 26, 27] . The XPF gene encodes a protein which, together with ERCC1, creates the 5 0 endonuclease [28] . The results of studies on XPF and ERCC1 variants and the risk of cancer are also contradictory [29] [30] [31] . The XPG gene encodes the 3 0 endonuclease of the NER pathway. The wild type allele of XPG (Asp1104His) has been shown to be associated with a decreased risk of lung cancer especially among light smokers and non-smokers [32] . There is a lack of available data on polymorphisms of the XPF and XPG genes and the risk of sCRC.
Homologous recombination repair (HR) is involved in the repair of double strand breaks (DSBs) [33] . The NBS1 (Nibrin) protein is a component of the MRN-complex, which recognizes DSBs [34] . Most studies investigating the NBS1 Glu185Gln polymorphism have focused on assessing the risk of breast cancer [35] . There is only one publication on this NBS1 polymorphism and risk of colorectal cancer [36] . The XRCC3 protein interacts with Rad51-related proteins in the process of homologous recombination. The C18067T (Thr241Met) variant of the XRCC3 gene in exon 7 modulates its function and is linked to an increased risk of bladder, breast, colorectal, lung and skin cancer [37] [38] [39] [40] [41] . Rad51 plays a crucial role in the HR pathway. The increased risk of endometrial cancer for the G135C variant of Rad51 have been shown as well as for breast cancer among carriers of the BRCA1 mutation [42, 43] . Recently it has been postulated that the above mentioned polymorphism of the Rad51 gene could be an independent marker of colorectal cancer risk [44] .
We aimed to find polymorphisms of the chosen DNArepair genes which modulate the risk of sCRC. We focused on the following genes: (1) OGG1 Ser326Cys, XRCC1 Trp194Arg and Arg399Gln (BER), (2) XPA (-4)G/A, XPC C/A (i11) and A33512C (Lys939Gln), XPD Asp312Asn and A18911C (Lys751Gln), XPF Arg415Gln, XPG Asp1104His, ERCC1 C118T (NER), (3) NBS1 Glu185Gln, Rad51 G135C, XRCC3 C18067T (Thr241Met) (HR).
Materials and methods

Patients and controls
The study and the control group consisted entirely of Polish individuals (all Caucasians), who came from the same geographic area (Lower Silesia). The study group consisted of 133 patients diagnosed with sporadic colorectal adenocarcinoma (sCRC). The mean age of the patients was 63.22 with a standard deviation of 11.36. Blood samples from the study group were collected from the 2nd Department of General and Oncological Surgery, Wroclaw Medical University and the Department of General Surgery, Regional Specialized Hospital, Wroclaw.
The control group consisted of 100 patients of the Department of Internal Diseases, Clinical Hospital, Swiebodzice, Poland. Their mean age was 74.89 with a standard deviation of 7.63. We decided to compose the control group of individuals approximately 15 years older on average than the cancer patients, because the risk of sCRC cancer is age-related. None of the control group suffered from cancer or had a family history of cancer.
The design of the study was accepted by the Wroclaw Medical University Ethics Committee and each of individual signed informed consent.
Analysis of the polymorphisms
Genomic DNA was isolated from peripheral blood lymphocytes using standard phenol-chloroform extraction and ethanol precipitation. The analyses of 14 SNPs in the following DNA-repair genes: OGG1, XRCC1, XPA, XPC, XPD, XPF, XPG, ERCC1, XRCC3, Rad 51 and NBS1, were carried out using a polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) assays as we have previously described [45] . To genotype OGG1 Ser326Cys, we employed the method of Le Marchand et al. [46] . The final products were analyzed using gel electrophoresis on a 2% agarose gel stained with ethidium bromide and visualized directly under UV light.
Statistical analysis
The Chi-squared goodness of fit test was used to test whether the genotype frequencies corresponded to the Hardy-Weinberg equilibrium and to test for linkage disequilibrium between pairs of loci. The frequencies of extended haplotypes were estimated using an iterative procedure based on a standard gene counting procedure [47] .
Fisher's exact test was used to assess differences in phenotype distribution between the two groups, firstly under the assumption that the non-wild type allele (assumed to be the least frequent allele) is dominant and secondly under the assumption that the non-wild type allele is recessive [48] . Logistic regression was used to derive of model for the likelihood of developing CRC given the genetic data. Statistical tests were performed using the SPSS and R software packages.
Results
We have determined the frequencies of 14 SNPs in 11 genes involved in three DNA repair pathways in sCRC patients compared to the control group. In the first step the loci were tested for agreement with the Hardy-Weinberg equilibrium and linkage disequilibrium.
The OGG1, RAD51, XPF polymorphisms and the polymorphism at codon 194 Arg/Trp of the XRCC1 were omitted from the analysis, since there was too little variation at these sites for the approximation used to be reliable. No significant deviations were observed from the Hardy-Weinberg equilibrium in the control group. Significant deviations from this equilibrium were found in the study group at the following loci: XPC intron 11 (P \ 0.001), ERCC1 C118T (P \ 0.01) and XPG Asp1104His (P \ 0.05). In the case of XPC intron 11, this result is significant at the 1% level, even when the Bonferroni correction is taken into account (based on the 10 sites considered). In both the sCRC-patient and control groups a significant level of linkage disequilibrium was observed for two pairs of polymorphisms (i) XPC A33512C (Lys939Gln) and XPC C/A (i11) (P \ 0.01 after the application of Bonferroni correction); (ii) XPD Asp312Asn and XPD A18911C (Lys751Gln) (P \ 0.001 after the application of Bonferroni correction).
The analysis of association between polymorphisms in a single gene and sCRC revealed a significant association between the XPC C/A (i11) locus and sCRC risk (recessive model, P = 0.038). The odds of a heterozygote with an A allele at this locus developing sCRC is estimated to be 2.07 times the odds for an individual with a C/C genotype. The 95% confidence interval for this odds ratio is [1.1391, 3.7782]. Moreover, individuals with an A/A were not significantly more likely to develop sCRC.
There was also a significant association between the XPD A18911C (Lys751Gln) polymorphism and the risk of sCRC (dominant model, P = 0.031). The odds of an individual with a C/C (A18911C) genotype developing sCRC is estimated to be 0.4497 times the odds for an individual with at least one A allele at this locus. The 95% confidence interval for this odds ratio is [0.2215, 0.9131] (see Table 1 ). No other associations were observed (see Table 2 , available online).
We also investigated the association between an individual's genotype based on a pair of loci and the risk of developing sCRC. A significant association was found for the following seven pairs of loci: (1) XRCC3 C18067T (Thr241Met)/RAD51 G135C (P = 0.01691, here due to their small number 135C/135C individuals were grouped with 135C/wt individuals), (2) XPG Asp1104His/ERCC1 C118T (P = 0.04297), (3) XPF Arg415Gln/XPC A33512C (Lys939Gln) (P = 0.01009), (4) XPC in(11)/XPC A33512C (Lys939Gln) (P = 0.009246), (5) XPC in(11)/ ERCC1 C118T (P = 0.04390), (6) XPC in(11)/XPF Arg415Gln (P = 0.01691), (7) XPD Asp312Asn/XPD A18911C (Lys751Gln) (P = 0.03596). Several models based on logistic regression were considered. In each case, factors were sequentially added to the model until no factor outside the model was significant. The first model considered sex and all the loci as possible factors. This model stated that taking into account sex (males are more susceptible), individuals with an A allele at XPC (i11) are more susceptible to sCRC (P = 0.013). In the second model considered, sex, the XPC (i11) locus and the XPD A18911C (Lys751Gln) were treated as possible factors, together with the genotypes based on the following three pairs of loci not including the two loci above (1) XRCC3 C18067T (Thr241Met)/RAD51 G/135C, (2) XPG Asp1104His/ ERCC1 C118T and (3) XPF Arg415Gln/XPC A33512C (Lys939Gln) (the most frequent double homozygote was used as a baseline for comparison in each case). Apart from the significant effect of XPC (i11) found in the previous model, this model found the following associations: XPF Arg415Gln/XPC A33512C (Lys939Gln)-double heterozygotes have a higher susceptibility to sCRC than Arg415Arg/A33512A (Lys939Lys) (the ''wild-type'' double homozygote, P \ 0.01). XRCC3 C18067T (Thr241Met)/ RAD51 G135C-CC (18067)/G135C individuals are more susceptible than CC (18067)/G135G individuals (P \ 0.05). XPG Asp1104His/ERCC1 C118T-GG/CT, GC/TT and CC/CT individuals are more susceptible to CRC that GG/TT individuals (P \ 0.05, P \ 0.05 and P \ 0.01, respectively). Due to the relatively low frequency of some of the genotypes, it is difficult to make strong conclusions based on these results. However, one interesting aspect is that for the three pairs considered in the analysis, double homozygotes showed a low level of susceptibility to sCRC.
Discussion
The complexity of the process of carcinogenesis, has led to a situation in which, despite tremendous research effort, the genetic etiology of sporadic cancers still remains largely uncovered. Yet the understanding of this complexity resulted in the multi-hit theory of cancer [49] , which seems to be more comprehensive with sporadic cancers than double-hit theory, which in turn seems to be more comprehensive with the etiology of hereditary cancers. Finally, an enormous number of papers focusing on associations between the risk of cancer and a variety of polymorphisms/mutations in DNA-repair genes have been published (frequently presenting conflicting results).
In the current study, among the 14 variants in 11 DNArepair genes analyzed, only variants of two genes: XPC C/A(i11) and XPD A18911C (Lys751Gln) were shown to be associated with sCRC risk. The carriers of the homozygous C/C A18911C (Lys751Gln) genotype at the XPD gene were at decreased (OR 0.4497 CI 95% 0.22-0.91), while individuals carrying C/A polymorphism in intron 11 at XPC gene at increased (OR 2.07 CI 95% 1.13-3.77) risk of sCRC.
Previously published data focusing on the role of XPD variants in the modulation of an individual's risk of developing various cancers, are scarce and often ambiguous. For example, the results of the study of Skjelbred CF et al. studies on Norwegian cohort suggested that XPD A18911C (Lys751Gln) variant is associated with an increased risk of low-risk adenomas, but not carcinomas [15] , while Hansen's RD et al. studies on 160,725 Danish individuals revealed that the XPD A18911C (Lys751Gln) variant is not of a major importance in colorectal carcinogenesis [22] . Results similar to those of Hansen et al. [22] were recently published by ref. [27] for Polish population Thus, the role of mentioned polymorphism of XPD in colorectal carcinogenesis seems to be still uncovered.
However, the data highlighting the role of XPC C/A (i11) in modulation of an individual risk of developing cancers, seems to be much more comprehensive.
The meta-analysis, carried out by Zhang et al. as well as Qiu et al. revealed that XPC is one of the most important genes modulating an individual's risk of developing sporadic cancer [48, 50] . Moreover, recent data on structurefunction relations of the XPC protein suggest that even a single amino acid alteration could be sufficient to compromise XPC function profoundly [51] . The results of our studies showing that XPC C/A (i11) individuals are at increased risk of sCRC are in agreement with these observations. An important role of XPC C/A (i11) in carcinogenesis probably results from the fact that the XPC intron 11 splice acceptor site polymorphism is related to an increased frequency of exon 12 skipping, leading thus to diminished DNA repair. Khan et al. reported that the homozygous variant A/A is associated with an approximately 50% reduction in DNA repair capacity (DRC) of the XPC protein [52] . This is consistent with the observations by Lopez-Cima et al., who found that the PAT?/ 33512C(939Gln)/intron11A haplotype contributed to reduced DNA repair capacity and thus, to an increased risk of lung cancer [53] .
In the current study we did not observe any increased risk of CRC to be associated with the homozygous variant (A/A) in intron 11 of XPC gene. This could be explained by the 'greater apoptosis' hypothesis, stating that adverse variants with lower DRCs may have a greater protective effect by increasing apoptosis rate. In fact, the results of our study are in agreement with the results of Huang et al., who found an association between 3 polymorphisms of the XPC gene (492R, 499A and 33512C) and the risk of colorectal adenoma, especially in smokers [54] . Tobacco carcinogens (like polycyclic aromatic hydrocarbons) may cause a DNA damage, while the XPC protein plays a crucial role in repairing of this type of damage [54] . The studies of Garcia-Closas et al. and Shen et al. revealed an association between the risk of cancer and a single XPC polymorphism, namely: between 33512C and the risk of bladder cancer, as well as the PAT ? polymorphism in intron 9 and the risk of squamous cell carcinoma of head and neck [55, 56] . However, taking into account the high LD between these XPC variants, it remains to be determined whether a single polymorphism or their association is of most importance in the modulation of cancer risk.
Interestingly, an in vitro experiment has confirmed the importance of the XPC C/A (i11) genotype in the preservation of genetic stability, by revealing that among young healthy individuals the XPC C/A (i11) genotype is associated with the frequency of bleomycin-induced chromosomal aberrations (CA) [45] . This controversial observation was published by Kazimirova et al., who showed that C/A heterozygotes had less chromosomal aberrations than comparing to C/C and A/A homozygotes [57] .
This discrepancy could result from an analysis of the relationships between a chromosomal end-point and a single genetic variant [57] , but not among a ''network'' of genetic alterations [45] .
We were also searching for an association between pairs of genetic variants and CRC risk. Our results have revealed that NER pathway-genes were present in all but one of gene-variant pairs, highlighted as most important in this process. All these data taken together, strongly suggest the potential role of the NER pathway (mainly of XPC), in ensuring of chromosomal stability and subsequently in the modulation of individual's risk of sporadic colorectal cancer.
Conclusions
On the basis of our study, in regard to relevant literature it can be stated that the XPC C/A (i11) is associated with an increased risk of sCRC.
Moreover, in spite of the fact that it is difficult to make strong conclusions based on the results of current studies in regard to the influence of networks of polymorphism in DNA repair genes on an individual's sCRC risk by (because of the relatively low frequency of some of the genotypes), our results strongly supports the thesis that ''it is necessary to access the combined effect of several polymorphisms in the same gene or between different genes that might contribute to cancer risk'' [48] .
